Potential of old-generation antibiotics to address current need for new antibiotics - PubMed (original) (raw)
Review
Potential of old-generation antibiotics to address current need for new antibiotics
Matthew E Falagas et al. Expert Rev Anti Infect Ther. 2008 Oct.
Abstract
Despite the constantly increasing need for new antimicrobial agents, antibiotic drug discovery and development seem to have greatly decelerated in recent years. Presented with the significant problem of advancing antimicrobial resistance, the global scientific community has attempted to find alternative solutions; one of the most promising ones is the evaluation and use of old antibiotic compounds. Due to the low-level use of many of the old antibiotic compounds, these have remained active against a large number of currently prevalent bacterial isolates. Thus, clinicians are beginning to re-evaluate their use in various patient populations and infections, despite the fact that they were previously thought to be less effective and/or more toxic than newer agents. A number of old antibiotic compounds, such as polymyxins, fosfomycin, fusidic acid, cotrimoxazole, aminoglycosides and chloramphenicol, are re-emerging as valuable alternatives for the treatment of difficult-to-treat infections. The availability of novel genetic and molecular modification methods provides hope that the toxicity and efficacy drawbacks presented by some of these agents can be surpassed in the future.
Similar articles
- Old antibiotics for infections in critically ill patients.
Falagas ME, Kopterides P. Falagas ME, et al. Curr Opin Crit Care. 2007 Oct;13(5):592-7. doi: 10.1097/MCC.0b013e32827851d7. Curr Opin Crit Care. 2007. PMID: 17762241 Review. - [Side effects of antibiotic therapy (review of the literature)].
Solov'ev VN, Berezhinskaia VV. Solov'ev VN, et al. Vopr Okhr Materin Det. 1974 Sep;19(9):63-9. Vopr Okhr Materin Det. 1974. PMID: 4370853 Review. Russian. No abstract available. - [Miscellaneous antibiotics].
Sawae Y. Sawae Y. Nihon Rinsho. 1990 Oct;48(10):2200-4. Nihon Rinsho. 1990. PMID: 2280465 Japanese. No abstract available. - Do we still need the aminoglycosides?
Durante-Mangoni E, Grammatikos A, Utili R, Falagas ME. Durante-Mangoni E, et al. Int J Antimicrob Agents. 2009 Mar;33(3):201-5. doi: 10.1016/j.ijantimicag.2008.09.001. Epub 2008 Oct 30. Int J Antimicrob Agents. 2009. PMID: 18976888 Review. - Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections.
Roussos N, Karageorgopoulos DE, Samonis G, Falagas ME. Roussos N, et al. Int J Antimicrob Agents. 2009 Dec;34(6):506-15. doi: 10.1016/j.ijantimicag.2009.08.013. Epub 2009 Oct 13. Int J Antimicrob Agents. 2009. PMID: 19828298 Review.
Cited by
- Efficacy of antimicrobial peptide P113 oral health care products on the reduction of oral bacteria number and dental plaque formation in a randomized clinical assessment.
Wu YF, Han BC, Lin WY, Wang SY, Linn TY, Hsu HW, Wen CC, Liu HY, Chen YH, Chang WJ. Wu YF, et al. J Dent Sci. 2024 Oct;19(4):2367-2376. doi: 10.1016/j.jds.2024.07.011. Epub 2024 Jul 19. J Dent Sci. 2024. PMID: 39347072 Free PMC article. - Microneedles as a potential platform for improving antibiotic delivery to bacterial infections.
Abid Al-Wahaab ZM, Al-Mayahy MH. Abid Al-Wahaab ZM, et al. Heliyon. 2024 Aug 29;10(17):e37173. doi: 10.1016/j.heliyon.2024.e37173. eCollection 2024 Sep 15. Heliyon. 2024. PMID: 39286069 Free PMC article. Review. - Novel N-doped carbon dots derived from citric acid and urea: fluorescent sensing for determination of metronidazole and cytotoxicity studies.
Qi H, Qiu L, Zhang X, Yi T, Jing J, Sami R, Alanazi SF, Alqahtani Z, Aljabri MD, Rahman MM. Qi H, et al. RSC Adv. 2023 Jan 18;13(4):2663-2671. doi: 10.1039/d2ra07150a. eCollection 2023 Jan 11. RSC Adv. 2023. PMID: 36741170 Free PMC article. - Assessing Clinical Potential of Old Antibiotics against Severe Infections by Multi-Drug-Resistant Gram-Negative Bacteria Using In Silico Modelling.
Paranos P, Vourli S, Pournaras S, Meletiadis J. Paranos P, et al. Pharmaceuticals (Basel). 2022 Nov 30;15(12):1501. doi: 10.3390/ph15121501. Pharmaceuticals (Basel). 2022. PMID: 36558952 Free PMC article. Review. - Resistance to Critical Important Antibacterials in Staphylococcus pseudintermedius Strains of Veterinary Origin.
Bellato A, Robino P, Stella MC, Scarrone L, Scalas D, Nebbia P. Bellato A, et al. Antibiotics (Basel). 2022 Dec 5;11(12):1758. doi: 10.3390/antibiotics11121758. Antibiotics (Basel). 2022. PMID: 36551415 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical